| Simulating the human colorectal cancer microenvironment in 3D tumor-stroma co-cultures in vitro and in vivo M Devarasetty, A Dominijanni, S Herberg, E Shelkey, A Skardal, S Soker Scientific reports 10 (1), 9832, 2020 | 43 | 2020 |
| Cell viability assays in three-dimensional hydrogels: a comparative study of accuracy AJ Dominijanni, M Devarasetty, SD Forsythe, KI Votanopoulos, S Soker Tissue Engineering Part C: Methods 27 (7), 401-410, 2021 | 33 | 2021 |
| Exploring the activity of a polyazine bridged Ru (II)–Pt (II) supramolecule in F98 rat malignant glioma cells J Zhu, JA Rodriguez-Corrales, R Prussin, Z Zhao, A Dominijanni, ... Chemical communications 53 (1), 145-148, 2017 | 27 | 2017 |
| Manipulating the tumor microenvironment in tumor organoids induces phenotypic changes and chemoresistance A Dominijanni, M Devarasetty, S Soker Iscience 23 (12), 2020 | 23 | 2020 |
| Dysregulated pyrimidine biosynthesis contributes to 5-FU resistance in SCLC patient-derived organoids but response to a novel polymeric fluoropyrimidine, CF10 WH Gmeiner, LD Miller, JW Chou, A Dominijanni, L Mutkus, F Marini, ... Cancers 12 (4), 788, 2020 | 23 | 2020 |
| Bioengineered tumor organoids A Dominijanni, A Mazzocchi, E Shelkey, S Forsythe, M Devarsetty, ... Current opinion in biomedical engineering 13, 168-173, 2020 | 19 | 2020 |
| Pushing the limits of structurally-diverse light-harvesting Ru (II) metal-organic chromophores for photodynamic therapy R Padilla, WA Maza, AJ Dominijanni, BSJ Winkel, AJ Morris, KJ Brewer Journal of Photochemistry and Photobiology A: Chemistry 322, 67-75, 2016 | 19 | 2016 |
| Improved potency of F10 relative to 5-fluorouracil in colorectal cancer cells with p53 mutations A Dominijanni, WH Gmeiner Cancer drug resistance (Alhambra, Calif.) 1, 48, 2018 | 18 | 2018 |
| Visible light-induced cytotoxicity of Ru, Os–polyazine complexes towards rat malignant glioma J Zhu, A Dominijanni, JÁ Rodríguez-Corrales, R Prussin, Z Zhao, T Li, ... Inorganica Chimica Acta 454, 155-161, 2017 | 13 | 2017 |
| Improved antitumor activity of the fluoropyrimidine polymer CF10 in preclinical colorectal cancer models through distinct mechanistic and pharmacologic properties WH Gmeiner, A Dominijanni, AO Haber, LP Ghiraldeli, DL Caudell, ... Molecular cancer therapeutics 20 (3), 553-563, 2021 | 9 | 2021 |
| Pleural effusion aspirate for use in 3D lung cancer modeling and chemotherapy screening A Mazzocchi, A Dominijanni, S Soker Biomedical Engineering Technologies: Volume 2, 471-483, 2022 | 6 | 2022 |
| Biofabricated 3D in vitro model of fibrosis‐induced abnormal hepatoblast/biliary progenitors' expansion of the developing liver M Brovold, D Keller, M Devarasetty, A Dominijanni, R Shirwaiker, S Soker Bioengineering & Translational Medicine 6 (3), e10207, 2021 | 5 | 2021 |
| Tissue organoid models and applications TS Leach, A Dominijanni, SV Murphy, A Atala Principles of Tissue Engineering, 1537-1549, 2020 | 4 | 2020 |
| Simulating the human tumor microenvironment in colorectal cancer organoids in vitro and in vivo M Devarasetty, A Dominijanni, S Herberg, E Shelkey, A Skardal, S Soker bioRxiv, 822684, 2019 | 1 | 2019 |
| Modeling of the Tumor Microenvironment in Tumor Organoids E Shelkey, A Dominijanni, S Forsythe, D Oommen, S Soker | | 2022 |
| MS and Shay Soker, Ph. D. AJ Dominijanni, M Devarasetty, S Forsythe ARCHITECTURAL PROPERTIES OF THE TUMOR MICROENVIRONMENT CONTROL CANCER …, 2021 | | 2021 |
| Organoids with modified tumor microenvironment architecture induces phenotypic changes in metastatic colorectal cancer A Dominijanni, S Soker CANCER RESEARCH 81 (5), 2021 | | 2021 |
| Abstract PO024: Organoids with modified tumor microenvironment architecture induces phenotypic changes in metastatic colorectal cancer A Dominijanni, S Soker Cancer Research 81 (5_Supplement), PO024-PO024, 2021 | | 2021 |
| Architectural Properties of the Tumor Microenvironment Control Cancer Progression A Dominijanni Wake Forest University, 2021 | | 2021 |
| Modeling the tumor microenvironment architecture of metastatic colorectal cancer in 3D organoids A Dominijanni Cancer Research 80 (16_Supplement), 3999-3999, 2020 | | 2020 |
